IPP Bureau
HealthEdge and UST HealthProof Merge to create AI-powered healthcare payer technology
By IPP Bureau - September 08, 2025
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plans
Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)
By IPP Bureau - September 08, 2025
He has been associated with the Zydus Group since 2009
Strides partners with Kenox to expand nasal spray portfolio for US market
By IPP Bureau - September 08, 2025
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
USFDA conducts product specific pre-approval inspection at Lupin’s Aurangabad facility
By IPP Bureau - September 08, 2025
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
FDA approves sBLA for Takeda's Vonvendi for Von Willebrand disease
By IPP Bureau - September 08, 2025
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
Aptar Pharma partners with Dianosic to advance ARIS platform for treatment of chronic allergic rhinitis and rhinosinusitis
By IPP Bureau - September 08, 2025
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Glenmark initiates multi-country Phase 3 clinical trial for Envafolimab in resectable Stage III NSCLC
By IPP Bureau - September 06, 2025
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Poly Medicure to acquire 90% stake in PendraCare Group for € 18.3 million
By IPP Bureau - September 06, 2025
PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEM’s
Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer
By IPP Bureau - September 06, 2025
Indegene opens new center in Pune
By IPP Bureau - September 06, 2025
Zydus Lifesciences gets 4 USFDA observations for Jarod Injectable facility
By IPP Bureau - September 06, 2025
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
iPHEX 2025: Piyush Goyal calls for deeper global collaborations to strengthen healthcare systems worldwide
By IPP Bureau - September 05, 2025
Goyal reaffirmed the government’s commitment to facilitating market access, reducing trade barriers, and ensuring that Indian exporters remain globally competitive
Granules India and NIPER S.A.S Nagar launch CoE for sustainable pharma innovation
By IPP Bureau - September 05, 2025
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
By IPP Bureau - September 05, 2025
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
MedTech Expo 2025: ICMR licenses nine technologies to 17 industry partners
By IPP Bureau - September 05, 2025
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
